Stay updated on Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page
- ChecktodayChange DetectedThis change adds a new revision entry v3.5.5 and removes the previous v3.5.4 in the study record history, reflecting an incremental update to the page’s version history.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision entry labeled v3.5.4 was added to the history and the previous v3.5.3 entry was removed, updating the page's revision metadata.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page’s software/version revision indicator was updated from v3.5.2 to v3.5.3, reflecting a general release-level change rather than an update to the trial history or study details.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the record history.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.1%

- Check86 days agoChange DetectedThe latest version adds a 'Study Status' entry to the history (revision v3.4.3, dated 2026-03-11); the prior revision (v3.4.2, 2025-12-24) is removed.SummaryDifference0.3%

Stay in the know with updates to Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page.